Tern Plc publishes presentations from Device Authority and Talking Medicines investor event

Tern plc

Tern Plc (LON:TERN), the investment company specialising in supporting high growth, early-stage, disruptive Internet of Things technology businesses, has announced that following its online presentation and a Q&A session yesterday evening involving Tern’s portfolio companies Device Authority and Talking Medicines, copies of the presentations from the participating companies can be found via the links below:

Device Authority presentation:  

Talking Medicines presentation:

In addition a recording of the event will shortly be available to view on Tern plc’s website at: https://www.ternplc.com/resources

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Talking Medicines targets messaging risk in pharma brand strategy

Talking Medicines reduces messaging risk for pharma brands by measuring real-time HCP response.

Agentless security for untouchable IoT devices

Agentless IoT security provides identity‑driven protection for devices that cannot be directly managed, turning blind spots into governed assets.

Virtual reality surgical training wins industry attention with scalable model

A new VR training solution backed by Orbis and Fundamental XR is gaining global traction by tackling real-world gaps in surgical education.

Tern Plc publishes presentations from Device Authority and Talking Medicines investor event

Tern Plc has released copies of the presentations delivered by portfolio companies Device Authority and Talking Medicines during its recent online investor presentation and Q&A session.

India and China push automotive cybersecurity in a new direction

India and China are setting new rules for automotive cybersecurity, and the manufacturers that keep up will be the ones that stay in the game.

Pharma faces a strategic turning point in AI adoption

AI in pharma is moving from operational support to strategic driver as companies prioritise messaging that delivers measurable prescriber impact.

Search

Search